FRNM

9.3605.69%
RE

Riley Ennis

Co-Founder & Chief Product Officer

Mr. Riley Ennis is Co-Founder of Freenome, Inc and has been its Chief Product Officer since September 2021. He was the COO & Secretary at Freenome, Inc. Mr. Ennis He heads the clinical and commercial development of Freenome’s noninvasive tests for early cancer detection and treatment selection. He serves as Director and Chief Operations Officer of Freenome Ltd. A Thiel Fellow, he developed a cancer vaccine and founded his first biotech company, Immudicon, while still in high school. While earning his degree in molecular biology at Dartmouth, he co-authored several publications and worked as a visiting scientist with Novartis. Along with his work as a scientist, he worked as an analyst at Morgan Stanley and an associate at Bridgewater, where he observed the positive impact of a strong organizational culture firsthand. His previous biotech experience includes work at Foundation Medicine, Syros Pharmaceuticals, Adimab and Emergent Biosolutions.

Positions